Highly rated in
Highly rated in
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Gabriel Pardo's experience treating your condition:
About Dr. Gabriel Pardo

Gabriel Pardo is a Neurologist and an Ophthalmologist in Oklahoma City, Oklahoma. Pardo has been practicing medicine for over 37 years and is highly rated in 6 conditions, according to our data. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica. He is licensed to treat patients in Oklahoma. Pardo is currently accepting new patients.

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 6 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gabriel Pardo it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Gabriel Pardo accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Oscar

Call to see if your plan is accepted.
820 Ne 15th St, Oklahoma City, OK 73104
Background & Education
Graduate Institution
Other, 1986
Psychiatry & Neurology in OK
Hospital Affiliations
OneCore Health
INTEGRIS Baptist Medical Center
Ascension St John Broken Arrow
Mercy Hospital Ardmore
Ascension St John Jane Phillips Medical Center
HPI Community Hospital - South Campus
INTEGRIS Jim Thorpe Rehabilitation
INTEGRIS Southwest Medical Center
SSM Health St Anthony Hospital - Oklahoma City
IU Health Methodist Hospital
Mercy Hospital Oklahoma City
Riley Hospital For Children At IU Health
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
Multi-center, Randomized, Double-blinded Assessment of Tecfidera® in Extending the Time to a First Attack in Radiologically Isolated Syndrome (RIS) (ARISE)
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors